Jane A Mitchell Selected Research

Jane A Mitchell Research Topics

Disease

15	Inflammation (Inflammations) 10/2020 - 02/2002
10	Pulmonary Arterial Hypertension 01/2021 - 09/2009
9	Pulmonary Hypertension 12/2023 - 11/2002
8	Thrombosis (Thrombus) 03/2024 - 10/2009
6	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 03/2003
6	Neoplasms (Cancer) 10/2020 - 01/2002
6	Vascular Remodeling 02/2015 - 11/2002
6	Infections 08/2013 - 10/2007
5	Sepsis (Septicemia) 01/2017 - 08/2002
5	Hypoxia (Hypoxemia) 02/2014 - 10/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 05/2009
5	Septic Shock (Toxic Shock Syndrome) 12/2010 - 08/2002
4	Atherosclerosis 01/2021 - 02/2013
4	Cytokine Release Syndrome 01/2016 - 04/2010
4	Chronic Hepatitis C 08/2013 - 01/2012
3	Virus Diseases (Viral Diseases) 01/2021 - 07/2012
3	Myocardial Infarction 12/2016 - 12/2006
3	Cardiomegaly (Heart Hypertrophy) 12/2013 - 03/2010
3	Asthma (Bronchial Asthma) 10/2009 - 03/2003
2	Hypertrophy 12/2023 - 03/2003
2	Carotid Artery Injuries 10/2023 - 10/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2023 - 10/2009
2	COVID-19 01/2021 - 11/2020
2	Pain (Aches) 01/2019 - 04/2005
2	Endotoxemia 12/2011 - 12/2010
2	Shock 12/2010 - 08/2002
2	Hypotension (Low Blood Pressure) 03/2007 - 07/2003
1	Fibrosis (Cirrhosis) 10/2023
1	Idiopathic Pulmonary Fibrosis 03/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2019
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2016
1	Intestinal Polyps 01/2016
1	Intestinal Neoplasms (Intestinal Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

10	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2023 - 11/2002
8	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 05/2004
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 11/2008
6	Endothelin-1 (Endothelin 1)IBA 02/2014 - 11/2002
5	InterferonsIBA 02/2014 - 01/2012
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2013 - 01/2002
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2020 - 01/2002
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018 - 11/2002
4	SmokeIBA 01/2015 - 07/2005
4	Proteins (Proteins, Gene)FDA Link 05/2012 - 02/2004
4	PPAR-betaIBA 03/2010 - 02/2006
4	LigandsIBA 10/2009 - 01/2002
3	Arginine (L-Arginine)FDA Link 03/2024 - 12/2016
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2024 - 11/2002
3	Vasodilator Agents (Vasodilators)IBA 12/2023 - 05/2011
3	ProstaglandinsIBA 10/2020 - 01/2002
3	EnzymesIBA 01/2019 - 01/2016
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2017 - 08/2002
3	Hormones (Hormone)IBA 12/2016 - 10/2007
3	TGN-1412 (TGN1412)IBA 06/2015 - 04/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2015 - 08/2002
3	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 12/2013 - 03/2010
3	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2012 - 06/2007
3	Vasoconstrictor AgentsIBA 10/2012 - 03/2007
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2010 - 01/2002
2	parecoxibIBA 03/2024 - 01/2011
2	treprostinil FDA Link 12/2023 - 02/2006
2	Purinergic P2Y Receptor AntagonistsIBA 12/2021 - 11/2010
2	Metal-Organic FrameworksIBA 01/2021 - 07/2017
2	EicosanoidsIBA 01/2020 - 01/2019
2	ThromboxanesIBA 01/2020 - 01/2011
2	Prostaglandin D2IBA 01/2020 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	CytokinesIBA 01/2016 - 02/2002
2	Monoclonal AntibodiesIBA 01/2016 - 04/2010
2	EndotoxinsIBA 12/2011 - 07/2003
2	Transcription Factors (Transcription Factor)IBA 12/2010 - 01/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2010 - 07/2003
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 02/2004 - 07/2003
1	NitratesIBA 02/2024
1	CalciumIBA 12/2023
1	nintedanibIBA 03/2023
1	Sildenafil Citrate (Viagra)FDA Link 01/2021
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2021
1	Cyclooxygenase 1IBA 01/2021
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 11/2020
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 11/2020
1	Serine Proteases (Serine Protease)IBA 11/2020
1	Angiotensin-Converting Enzyme 2IBA 11/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Epoprostenol ReceptorsIBA 10/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	AminesIBA 01/2017
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 12/2016
1	CateninsIBA 01/2016
1	2-(6-methoxy-napthalen-2-yl)-propionic acid 4-thiocarbamoyl-phenyl esterIBA 01/2016
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2016

Therapy/Procedure

13	Therapeutics 01/2019 - 01/2002
2	Critical Care (Surgical Intensive Care) 12/2011 - 06/2009
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018
1	Chemoprevention 01/2016